Lataa...
Trimetazidine Increases Plasma MicroRNA-24 and MicroRNA-126 Levels and Improves Dyslipidemia, Inflammation and Hypotension in Diabetic Rats
Trimetazidine (TMZ) improves endothelial dysfunction. However, its beneficial effect on endothelial miRNAs is unexplored in diabetes. The aim of the present study was to evaluate the effects of TMZ on plasma miRNA-24 and miRNA-126, dyslipidemia, inflammation, and blood pressure in the diabetic rats....
Tallennettuna:
| Julkaisussa: | Iran J Pharm Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Shaheed Beheshti University of Medical Sciences
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7757984/ https://ncbi.nlm.nih.gov/pubmed/33680027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2020.1101144 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|